Softbank Vision Fund (aiv M2) L.P.
10% Owner

Softbank Vision Fund (aiv M2) L.P. insider trades: Relay Therapeutics (RLAY) stock sales

10% Owner, Relay Therapeutics Last trade Aug 25, 2026 8 Form 4 filings
$133.3M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2021
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Softbank Vision Fund (aiv M2) L.P. reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 25, 2026RLAY↓ Sell$116.4M
Jan 15, 2026NRGV↓ Sell$16.9M
Oct 27, 2021DASH↓ Sell$2.03B
Aug 19, 2021DASH↓ Sell$2.06B
May 19, 2021DASH↓ Sell$1.06B

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RLAY insiders

Open-market trades in the last 12 months

About Softbank Vision Fund (aiv M2) L.P.'s insider trades

Softbank Vision Fund (aiv M2) L.P. is a 10% owner of Relay Therapeutics (RLAY). Since May 19, 2021, it has reported no open-market purchases and 5 sales worth $5.28B on SEC Form 4. In the last 12 months: 2 sales ($133.3M).

Its filings also include conversions (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.